These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Tseng WP Environ Health Perspect; 1977 Aug; 19():109-19. PubMed ID: 908285 [TBL] [Abstract][Full Text] [Related]
5. A critical review of epidemiologic studies on black-foot disease. Ko YC J UOEH; 1986 Sep; 8(3):339-53. PubMed ID: 3532269 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. Tseng WP; Chu HM; How SW; Fong JM; Lin CS; Yeh S J Natl Cancer Inst; 1968 Mar; 40(3):453-63. PubMed ID: 5644201 [No Abstract] [Full Text] [Related]
8. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Tseng CH Angiology; 2002; 53(5):529-37. PubMed ID: 12365859 [TBL] [Abstract][Full Text] [Related]
9. [Studies on fluorescent compounds in drinking water of blackfoot disease endemic areas. 6. A preliminary experimental study on peripheral vasculopathy (author's transl)]. Lu FJ; Ling KH Taiwan Yi Xue Hui Za Zhi; 1979 Apr; 78(4):314-9. PubMed ID: 288828 [No Abstract] [Full Text] [Related]
10. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Chen CJ; Chuang YC; You SL; Lin TM; Wu HY Br J Cancer; 1986 Mar; 53(3):399-405. PubMed ID: 3964542 [TBL] [Abstract][Full Text] [Related]
11. [Study on distribution of endemic arsenism in China]. Jin Y; Liang C; He G; Cao J Wei Sheng Yan Jiu; 2003 Nov; 32(6):519-40. PubMed ID: 14963897 [TBL] [Abstract][Full Text] [Related]
12. Endemic chronic arsenism in Xinjiang. Huang YZ; Qian XC; Wang GQ; Xiao BY; Ren DD; Feng ZY; Wu JY; Xu RJ; Zhang FE Chin Med J (Engl); 1985 Mar; 98(3):219-22. PubMed ID: 3924515 [No Abstract] [Full Text] [Related]
13. A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Ch'i IC; Blackwell RQ Am J Epidemiol; 1968 Jul; 88(1):7-24. PubMed ID: 5661537 [No Abstract] [Full Text] [Related]
14. [Further studies on fluorescent compounds in drinking water of blackfoot endemic areas (author's transl)]. Lu FJ; Lin ST; Liao LL; Ling KH Taiwan Yi Xue Hui Za Zhi; 1980 Dec; 79(12):1094-101. PubMed ID: 6943289 [No Abstract] [Full Text] [Related]
15. Skin cancer in chronic arsenicism. Yeh S Hum Pathol; 1973 Dec; 4(4):469-85. PubMed ID: 4750817 [No Abstract] [Full Text] [Related]
16. Systemic arterial disease with myocardial infarction. Report on two infants. Rosenberg HG Circulation; 1973 Feb; 47(2):270-5. PubMed ID: 4684927 [No Abstract] [Full Text] [Related]
17. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Tseng CH; Chong CK; Chen CJ; Tai TY Atherosclerosis; 1996 Feb; 120(1-2):125-33. PubMed ID: 8645353 [TBL] [Abstract][Full Text] [Related]
18. Arsenic and lipid peroxidation in patients with blackfoot disease. Lin TH; Huang YL; Tseng WC Bull Environ Contam Toxicol; 1995 Apr; 54(4):488-93. PubMed ID: 7767024 [No Abstract] [Full Text] [Related]
19. An overview on chronic arsenism via drinking water in PR China. Xia Y; Liu J Toxicology; 2004 May; 198(1-3):25-9. PubMed ID: 15138026 [TBL] [Abstract][Full Text] [Related]
20. [Physico-chemical characteristics of drinking water in blackfoot endemic areas in Chia-I and Tainan Hsiens]. Lu FJ; Yang CK; Ling KH Taiwan Yi Xue Hui Za Zhi; 1975 Sep; 74(9):596-605. PubMed ID: 1062504 [No Abstract] [Full Text] [Related] [Next] [New Search]